Literature DB >> 1315794

Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement.

M Froldi1, A Castagna, M Parma, A Piona, A Tedeschi, A Miadonna, M Lorini, E N Orazio, A Lazzarin.   

Abstract

In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4), leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315794     DOI: 10.1016/0165-5728(92)90100-y

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Association of Plasma Eicosanoid Levels With Immune, Viral, and Cognitive Outcomes in People With HIV.

Authors:  Pragney Deme; Mohammed Moniruzzaman; David Moore; Robert Heaton; Ronald Ellis; Scott Letendre; Norman Haughey
Journal:  Neurology       Date:  2022-07-18       Impact factor: 11.800

2.  YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor.

Authors:  Dafna Bonneh-Barkay; Stephanie J Bissel; Gouji Wang; Kenneth N Fish; Georgina C B Nicholl; Samuel W Darko; Rafael Medina-Flores; Michael Murphey-Corb; Premeela A Rajakumar; Julia Nyaundi; John W Mellors; Robert Bowser; Clayton A Wiley
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

Review 3.  Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.

Authors:  Jonathan Bertin; Corinne Barat; Sylvie Méthot; Michel J Tremblay
Journal:  Retrovirology       Date:  2012-01-11       Impact factor: 4.602

4.  Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells.

Authors:  Jonathan Bertin; Corinne Barat; Dave Bélanger; Michel J Tremblay
Journal:  J Neuroinflammation       Date:  2012-03-16       Impact factor: 8.322

5.  Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.

Authors:  Vez Repunte-Canonigo; Celine Lefebvre; Olivier George; Tomoya Kawamura; Marisela Morales; George F Koob; Andrea Califano; Eliezer Masliah; Pietro Paolo Sanna
Journal:  Mol Neurodegener       Date:  2014-07-01       Impact factor: 14.195

6.  Arachidonic Acid Cascade and Eicosanoid Production Are Elevated While LTC4 Synthase Modulates the Lipidomics Profile in the Brain of the HIVgp120-Transgenic Mouse Model of NeuroHIV.

Authors:  Nina Y Yuan; Ricky Maung; Ziying Xu; Xianlin Han; Marcus Kaul
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

7.  Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.

Authors:  Bruno Caetano Trindade; Carlos Artério Sorgi; Larissa Deadame de Figueiredo Nicolete; Tathiane Maistro Malta; Mariana Tomazini Pinto; Osvaldo Massaiti Takayanagui; Dimas Tadeu Covas; Olindo Assis Martins Filho; Simone Kashima; Lúcia Helena Faccioli
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals.

Authors:  Sergio Serrano-Villar; David Rojo; Mónica Martínez-Martínez; Simon Deusch; Jorge F Vázquez-Castellanos; Rafael Bargiela; Talía Sainz; Mar Vera; Santiago Moreno; Vicente Estrada; María José Gosalbes; Amparo Latorre; Jana Seifert; Coral Barbas; Andrés Moya; Manuel Ferrer
Journal:  EBioMedicine       Date:  2016-04-27       Impact factor: 8.143

Review 9.  Virus-cell interactions in the nervous system and the role of the immune response.

Authors:  S B Wharton; A A Nash
Journal:  Curr Opin Neurobiol       Date:  1993-10       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.